Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
From toyin, https://seekingalpha.com/news/3855105-vaxart-says-recent-cro-agreement-may-be-integral-to-oral-covid-vaccine-success
'Every little helps'.
Fair play, you nearly got me to bite. 300 posts in 2 weeks of LSe membership . Good luck with the trolling.
What are you talking about ? who is they and what are 'they' testing ?
No offence meant but maybe you should go back and read the RNS again. Characterisation study not due to complete until q4 2022, testing expected early 2023.
this dude JazzzaGe
Some poster called Jazz????? said there was a contract - but he used choice words obviously been deleted !
I have no idea?
Enlighten me - what contract ?
Plenty of volume returning here including several 200,000 plus deals in the past week and the 10million plus trade yesterday. Also some big buys going through on Poolbeg Pharma also, is something cooking in the background? ADYOR!!!
As I said yesterday, looks like someone stake building with 250k and 300k late buys going through over the past week or so...? Interesting times ahead me thinks?
Great to see large buys again with a 4:1 buy to sell ratio for today. Why is the share price still down?
More big buys going through late in the day 250k and 300k building on last week's big buys..is someone stake building?, the buyers are certainly soaking up the 100k sells easily. With the AGM resolution no.9 allowing 67million shares to be purchased, it could be a good build up for the six months trading update. I feel plenty more large contracts waiting to be signed off. Very Big moat and Open Orphan currently sole global provider in many of it's markets with the big pharmaceuticals. Aimho Adyor!!! GLA
Interesting